Business
Harvest One launches Satipharm reformulated CBD capsules in Europe
Harvest One launches Satipharm reformulated CBD capsules in Europe Canada NewsWire...
About this update from Delivra Health Brands Inc
[{"type":"text","content":"\n\n\n\nHarvest One launches Satipharm reformulated CBD capsules in Europe\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Jan. 29, 2019\n\n\n\nTSX-V: HVT; OTCQX: HRVOF\n\n VANCOUVER, Jan. 29, 2019 /CNW/ - Harvest One Cannabis Inc. (\"Harvest One\" or the \"Company\") (TSX-V: HVT; OTCQX: HRVOF), announces that its wholly-owned medical subsidiary Satipharm Ltd. (\"Satipharm\") has launched European sales of its recently reformulated CBD capsules, now available online at www.satipharm.com. The first product to market is the Satipharm 10mg CBD Gelpell® capsule that provides superior bioavailability and quality. Bricks and mortar distribution of the 10mg CBD Gelpell® capsules will follow with major retailers throughout the United Kingdom and European Union, with Canadian distribution to follow. \n\n \n \n\n \n\"We are delighted with the launch of Satipharm's new website and eCommerce platform, making our clinically proven CBD Gelpell® capsules available to consumers across Europe,\" said Jonathan Hartshorn, President of Satipharm. \"With our focus on consumer education, GMP certified products, and superior bioavailability, we feel strongly that consumers will adopt Satipharm's CBD Gelpell® capsules as the product of choice for CBD delivery in the marketplace.\" \n\"The launch of Satipharm's patented CBD Gelpell® formulated capsules is an integral part of Harvest One's health and wellness strategy,\" said Grant Froese, CEO of Harvest One. \"We are very pleased to bring this innovative delivery technology to market and we look forward to the launch of additional product lines as we advance our health and wellness strategy in regulated markets around the world.\"\nSatipharm Gelpell® Technology\nSatipharm's Gelpell® technology improves the body's absorption of CBD and other cannabinoids through a patented formulation of CBD hemp extract contained in seamless Gelpell® gelatine biospheres. The Gelpell® biospheres are placed in gastro-resistant capsules ensuring the timely release of CBD in the sma...